Is there a truly traceable track for the tumor target?

doi:10.15406/oajtmr.2018.02.00046

Open Access Journal of

eISSN: 2576-4578

Translational Medicine & Research

Mini Review Volume 2 Issue 3

Is there a truly traceable track for the tumor target?

Wilson IB Onuigbo

Verify Captcha

Regret for the inconvenience: we are taking measures to prevent fraudulent form submissions by extractors and page crawlers. Please type the correct Captcha word to see email ID.

Pathology Department, Medical Foundation and Clinic, Nigeria

Correspondence: Wilson IB Onuigbo, Pathology Department, Medical Foundation & Clinic, 8 Nsukka Lane, Enugu 400001, Nigeria, Tel +2348037208680

Received: February 26, 2018 | Published: June 4, 2018

Citation: Onuigbo WIB. Is there a truly traceable track for the tumor target? Open Access J Trans Med Res. 2018;2(3):97-98. DOI: 10.15406/oajtmr.2018.02.00046

Download PDF

Abstract

The author recorded the history of both the attempts at cancer cure and how the autopsy had been revealing nature`s principles regarding possible target therapy. Actually, the visionary views of the medical masters of yester years pointed to present prospects of target therapy. Indeed, the author is persuaded that there is a traceable track which the translational system should seek because it is likely to be effective in looking for the target therapy of cancer.

Keywords: cancer, history, choriocarcinoma, cure, general principles

Mini review

Cancer treatment has long bothered mankind. The modern trend was well appreciated by Sir Michael Woodruff.¹ As he put it in a Review Lecture back in 1973, cancer is man’s “elusive enemy.”

The author documented the age-old problems of dispensing curative drugs.² This was done in conjunction with human models in cancer metastasis research.

A personal paper also presented the visionary views of the medical masters of yester years.³ In particular, these were directed to understanding Nature’s norms which point to present prospects concerning the target therapy of cancer. From another angle, it was shown that the old autopsy experience was revealing Nature’s principles for advancing current cancer research including target therapy.⁴Moreover, it was asked whether there was a translational system suitable for the target therapy of lung cancer in particular.⁵

The answer can be based on the Mono-Block Formalin-Fixation Method for investigating lung cancer.⁶ Using it, the thoracic duct was obtained as one whole, then Swiss-rolled and finally cut as a single microscope slide.⁷ Thereafter, it was seen that, when erythrocytes are commingled with cancer cells, necrosis occurs in this lymphatic microenvironment.⁸

It has since been argued that such necrosis is due to an underlying Natural Factor which should be called the “Erythrocyte Necrosis Associated Factor”.⁹ In all probability, purposive researches should reveal this Factor when carried out in order strictly thus:

Cannulating of the thoracic duct.¹⁰
Using consenting patients.¹¹
Employing the intravital videomicroscope.¹²

Indeed, the author’s experience was the serendipitous one not only seeing lively cancer cells but also necrotic cancer cells with aggregated red cells.⁷ In other words, the requirements of 2 subsets in research were occurring in this microenvironment.¹³ In order to further strengthen the enticing theory, one should propose some angles for its validation.^14–16

Now, there was a time that choriocarcinoma was in a similar situation.¹⁷ Then, Roy Hertz discovered its cure.¹⁸ Therefore, there is now the need for other conquests with special reference to the target therapy of cancer.

In this connection, Thiele and Sleeman instanced “Recent advances in understanding the biopsy of lymphangiogenesis, the new growth of lymphatic vessels”.¹⁹ Incidentally, as far back as 1963, the author delineated the position of the earliest deposits of lung cancer deposits in centrifugally disposed abdominal lymph nodes.²⁰Indeed, with 6 comments, such newness of growth was mentioned. Perhaps, the lack of the key-word system at that time prevented the recognition of this phenomenon earlier.^21,22

It is great that Gurt recently outlined cancer drug development in new targets for cancer treatment.²³ Moreover, Chabner and Roberts have also chronicled the history of modern chemotherapy and identified the remaining challenges for the next generation of researches.²⁴ Indeed, there is need to support their own challenge and that of Coleman²⁵ who pointed to the influencing role of the medical-industrial complex.

Conclusion

This mini-review has been based with personal choice on lung cancer because it is a superlatively located growth whose dispersed deposits surprisingly manifest as many as 10 anomalies.²⁶In this context, Melville Arnott,²⁷ during an exciting Memorial Lecture in 1955, advised that anomalies should always be worthy of research because they are Nature’s ways of indicating such fronts. Indeed, in this mini-review, the pointing has been to the truly traceable track on which the efforts of translational researches should end with the target therapy of man’s “elusive enemy!”